Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Andrew Left

Short Seller Andrew Left Recalls Bet On Nebius As It Soars Over 130% In 2025: 'Just A Pat On The Back' From When NBIS Was At $20 Per Share

Famed short-seller Andrew Left of Citron Research is taking a victory lap on a bullish call, celebrating his firm’s early bet on AI infrastructure company Nebius Group NV (NASDAQ:NBIS).

Benzinga

Opendoor Attacked By Short Seller—Stock Pops Anyway

Citron Research, led by famed short-seller Andrew Left, targeted Opendoor Technologies, Inc. (NASDAQ:OPEN) in a social media post on Friday. Opendoor investors shrugged off the attack, and the stock climbed.

Benzinga

Jim Cramer Sees Palantir Riding MongoDB's Momentum: Sets Bold 24% Upside Target — Says 'Bears Didn't See Mongo Coming!'

Television host Jim Cramer is once again reiterating his bullish stance on Palantir Technologies Inc. (NASDAQ:PLTR), tying the stock’s potential and his latest price target to the recent surge in MongoDB Inc. (NASDAQ:MDB).

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Palantir New All-Time Highs In 2025? Less Than 50% Say Yes In New Poll

Palantir Technologies (NASDAQ:PLTR) stock has gained more than 100% year-to-date, hitting new all-time highs in August before a recent pullback.

Benzinga

Palantir's AI Edge: PEG Ratio Outshines Salesforce—'Sleeper Valuation' Defying P/E Skeptics?

In a landscape where high Price-to-Earnings (P/E) ratios often scare investors, a different metric defies skeptics that AI powerhouse, Palantir Technologies Inc. (NASDAQ:PLTR), which was battered last week for its high valuations following a Citron Research report, is not quite overpriced.

Benzinga

How AI darling Palantir became the S&P 500’s best and worst stock of 2025, climbing 144% before shedding value in 6 straight sessions

Over $73 billion has been wiped off high-flying Palantir’s market cap in recent days.

Fortune

PLTR Stock Has Declined Over 15% In Past 5 Sessions, But This Tech Bull Says Palantir Remains 'Favorite'

Despite a sharp sell-off that has seen Palantir Technologies Inc. (NYSE:PLTR) shares plummet nearly 15% in the last five sessions, Wedbush Securities analyst Dan Ives is urging investors to see the dip as a buying opportunity.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Palantir Short Seller Andrew Left's Citron Now Compares It To Databricks: 'PLTR Is A $40 Stock, And Every Real AI Leader Keeps Reminding Us'

Short-seller Andrew Left‘s Citron Research intensified its campaign against Palantir Technologies Inc. (NYSE:PLTR) on Wednesday, posting a direct comparison to private competitor Databricks that highlights Palantir’s slower growth on several key metrics.

Benzinga

Short Seller Andrew Left Says 'OpenAI At $500 Billion Puts Palantir At $40' — And That's Generous

Renowned short-seller Andrew Left's Citron Research has issued a bearish report on Palantir Technologies Inc. (NASDAQ:PLTR), arguing the stock is significantly overvalued and its price is "detached from fundamentals and analysis".

Benzinga

Marjorie Taylor Greene Keeps Buying UnitedHealth Stock Along With Fellow Investors Buffett And Burry

Shares of UnitedHealth Group (NYSE:UNH) soared on Friday with news that several prominent investors had purchased shares of the health insurance company.

Benzinga

GameStop Short Seller Bets Against Palantir — Goes Long UnitedHealth Alongside Buffett, Burry

UnitedHealth Group (NYSE:UNH) stock is soaring Friday morning with a handful of large investors revealing long positions in the health insurance company via quarterly 13F filings.

Benzinga

Short Seller Slams Jim Cramer Over Palantir, Accuses Him Of Hyping 'High-Multiple, Hype-Driven Narrative' After $200 Price Target Call

Famed short-seller Andrew Left's Citron Research publicly challenged CNBC's Jim Cramer over his bullish stance on Palantir Technologies Inc. (NASDAQ:PLTR).

Benzinga

GameStop Short Seller Andrew Left Is Taking On Retail Investors Again, Now Says Palantir Stock Is 'Beyond Overvalued'

Citron Research founder and famed short seller Andrew Left announced a new short pick on Wednesday during an appearance on Fox Business.

Benzinga

Andrew Left Doubles Down On Rocket Companies: 'This Isn't A Meme,' It's A 'Housing Juggernaut' In The Making (CORRECTED)

Editor's Note: This article has been updated to correct the individual’s name in the headline.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

Prince Andrew 'unsurprised' by accuser Virginia Giuffre's car crash claims, friends of Duke say

The campaigner, who accused the Duke of York of sexually abusing her when she was 17, revealed she had ‘days to live’ following the collision with a school bus in Australia

Evening Standard

What happened to Virginia Giuffre? Everything we know as Epstein accuser 'fights for life' after car crash

The sex trafficking survivor shocked fans on Monday after revealing she was hit by a bus and has ‘days to live’

Barchart

Citron Research Just Identified This 1 Stock to Buy as a ‘Hidden’ AI Winner

Former short seller Citron Research is growing bullish on Teladoc's growth potential.

Fortune

Are famous short-sellers going extinct? The exit of Hindenburg Research and Andrew Left shows the risky trade is shrinking

Indicted short-seller Andrew Left tells Fortune a chilling effect is making “everyone think twice.”

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Andrew Left's Citron Research Says Nvidia-Backed Nebius Is The Next 'AI Wall Street Darling' — Stock Moves Up 14%

Shares of Nebius Group NV (NASDAQ:NBIS) jumped 13.90% on Tuesday after Citron Research highlighted the company’s potential to become the next artificial intelligence sensation on Wall Street, citing its deep ties with NVIDIA Corp. (NASDAQ:

Top News

Short Seller Andrew Left Charged With Securities Fraud Scheme

Short seller Andrew Left charged with securities fraud for manipulating stock prices through Citron Research. SEC also pursuing charges in a million fr...

Fortune

Short-seller Andrew Left is betting against GameStop again, undaunted by his 100% loss last time

When meme-stock traders' de facto leader posted a screenshot implying he owns over $100 million of GameStop, Andrew Left immediately shorted the stock.

Zenger

Citron Research Founder Andrew Left Lives In Fear Amidst GameStop Fallout

Left worries about potential charges as federal agencies probe activist short sellers

Benzinga

Crypto Bull Kevin O'Leary Vs. Bear Andrew Left: Who Will Win The Tug of War?

Even as the cryptocurrency market on Monday reclaimed the $1 trillion market cap following a dramatic fall in prices of late, there could be more pain ahead for investors in the short term, according to experts.

Benzinga

EXCLUSIVE: Short Seller Andrew Left Says The Idea Of Decentralization Is The 'Stupidest Thing Ever'

Andrew Left, founder of Citron Research says the idea of decentralization, where power is shifted from the hands of centralized entities is the “stupidest thing ever” and pointed out that the only utility Bitcoin has is that it is a collective consciousness of people, with people buying because others are.

Benzinga

Citron Research Targets Bitcoin, Ethereum, NFTs After Staying On Sidelines For 18 Months

A well-known figure from the David vs. Goliath story involving video game retailer GameStop Corp (NYSE: GME) that pitted retail traders against hedge funds and short-sellers has sights set on the cryptocurrency investors.

1 2

People

Marjorie Taylor Greene

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.